This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
s CDC Vaccine Committee Overhaul for the Pharmaceutical Industry June 10, 2025 By Christopher Cole News Article The dismissal of all 17 members of the Advisory Committee on Immunization Practices has far-reaching impacts for the industry and beyond. Washington, DC, USA - June 24, 2022: The symbol of the U.S. Press Release. June 9, 2025.
Voices Q&A Profiles Biotech Spotlight First 90 Days Opinions Topics Biotech Commercialization Leadership Manufacturing Patient Pharma Policy & Regulation Research & Development Library Events Press Releases PharmaVoice 100 Nominate 2024 PV100 2023 PV100 Sign up Search Sign up Search An article from Megablockbusters are the holy grail.
In this article, we’ll explore 10 innovative trends in pharma marketing that can set you up for success in this rapidly evolving landscape. From eco-friendly packaging to socially responsible campaigns, sustainability resonates with today’s consumers. Learn more about compliance tips at Pharma Marketing.
In an article published here ten days back, I provided a detailed account of a most worrying case where counterfeiters succeeded in acquiring batch-specific serial numbers of Sun Pharmas anti-epileptic drug Levipil 500, which were then embedded into QR codes on fake packages. Sun Pharma needs to flip that switch off right away.
In this article an infectious diseases pharmacist discusses five interesting things to know about sulopenem (Orlynvah). In this article I will go intofive interesting things about solupenem. The package insert for sulopenem recommends taking it with food to maximize bioavailability. Orlynvah [package insert].
The associations explained this is enabled through multi-country packs which are simplified by the language exemption and harmonised labelling requirements.
The new facility will feature state-of-the-art cleanroom packaging and high-sensitivity analytical testing capabilities. Communication between the manufacturing plant and retail stores. as part of the company’s commitment to providing a reliable supply of bioprocessing ingredients and excipients to the biopharma and pharmaceutical industries.
In this article, we spotlight the most influential pharma podcasts of 2025 and explain why they’re worth tuning into. From cold chain logistics to sustainability in packaging, it offers crucial insights for manufacturing and operations leaders. Episodes often explore digital therapeutics, wearable tech, and DTC campaigns.
Published July 8, 2025 By Kelly Bilodeau post share post print email license Stock via Getty Images Listen to the article 5 min This audio is auto-generated.
Published July 7, 2025 Amy Baxter Staff Reporter post share post print email license stock via Getty Images Listen to the article 6 min This audio is auto-generated.
Given that multiple work packages may often start or end together, or else take longer than others ( Figure 1 ), the introduction of new PAT requires assessment and planning by multiple departments. Figure 1 : Process analytical technology implementation in (bio)pharmaceutical GMP manufacturing.
This article explores the potential impact of the proposal and considers how manufacturers can ensure the safety and reliability of their products. However, given that PFAS are ubiquitous in the environment from stain-resistant carpets and non-stick pans, to packaging and electronics, to name a few the task is not that simple.
This article examines the various types of microorganisms commonly found in pharmaceutical production environments and explores the factors that influence their growth and survival. – Be alert to damaged packages. This ensures that the manufactured products are of high quality, safe, and pure.
I'm talking about Good Manufacturing Practice (GMP), a set of guidelines that govern the production, testing, and packaging of generic drugs. Read the full article on the role of GMP in generic drug manufacturing and how it ensures quality and safety: [link] Share your thoughts in the comments below!
Published June 27, 2025 Meagan Parrish Lead Editor post share post print email license Justin Sullivan via Getty Images Listen to the article 7 min This audio is auto-generated.
From packaging to proprietary coatings to the APIs themselves, nearly every prescription bottle represents a mosaic of global logistics. It would cascade through packaging providers, logistics companies, and digital vendors managing real-time supply chain dashboards. Imposing 200% pharma tariffs could fracture this delicate network.
Voices Q&A Profiles Biotech Spotlight First 90 Days Opinions Topics Biotech Commercialization Leadership Manufacturing Patient Pharma Policy & Regulation Research & Development Library Events Press Releases PharmaVoice 100 Nominate 2024 PV100 2023 PV100 Sign up Search Sign up Search An article from Is biopharma dealmaking getting hot again?
Challener News Article Pharmaceutical Technology Pharmaceutical Technology June 2025 Volume 49 Issue 5 Unique surface properties and ligand functionalization provide real advantages. Efficient and effective delivery of complex and challenging drug substances is an ongoing issue facing developers of modern medicines. & & Tech.
1,3 According to the package insert for Gammagard Liquid ERC, it is contraindicated in patients with severe systemic hypersensitivity or anaphylactic reactions to the product.
Detect-A-Dose lid-label cover enhances medication recognition, reducing packaging errors through a contrasting visual pattern. 2 A prominent aspect of this issue that manufacturers have tried to tackle is medication recognition when transferring pills to containers and packaging. 1-3 Detect-A-Dose Lid Label Covers.
Recent Videos Related Content BASF Opens GMP Manufacturing Facility in Michigan Susan Haigney June 19th 2025 Article The new facility offers cleanroom packaging and high-sensitivity analytical testing. Hand shaking which print screen on wooden cube block in front of human icon for business deal and agreement concept.
This article explores why E&L studies go wrong and how to build a submission-ready package from protocol to final report. However, in our experience at SG Pharma Solutions, more than 60 per cent of initial E&L submissions get flagged. The reason?
Recent Videos Related Content Elkedonia Raises €11.25M Seed Round to Advance Neuroplastogen Therapy for Depression Christopher Cole June 11th 2025 Article Elkedonia will develop first-in-class Elk1 inhibitors for treatment-resistant depression, targeting neuroplasticity without psychedelic side effects.
Along with the successful pivotal trials, Launch-HTN and Advance-HTN, and the ongoing open-label extension trial, these results comprise the core package for our planned NDA submission.” Explore-CKD established that lorundrostat 25 mg once daily has a favorable clinical profile for this patient population.
In the EU, the EU pharmaceutical package of reform 5 includes a proposed new Directive, 6 which will replace the current Medicines Directive (2001/83/EC). That proposed Directive contains a similar regulatory framework for decentralised manufacturing (see prospective Articles 142-153). But the UK framework will arrive first.
In this article, GlobalData investigates key reimbursement trends that reflect the current delays to patient access across the European region. Alex Watt June 9, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The delays in market access in individual EU member states have been an obstacle to the industry.
Recent Videos Related Content BASF Opens GMP Manufacturing Facility in Michigan Susan Haigney June 19th 2025 Article The new facility offers cleanroom packaging and high-sensitivity analytical testing. BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer. Press Release. June 12, 2025.
Published June 25, 2025 Amy Baxter Staff Reporter post share post print email license Stock via Getty Images Listen to the article 7 min This audio is auto-generated. Here’s how drugmakers are getting there.
Package insert. FDA approves tablet formulation of BeOne's BRUKINSA for all approved indications. News Release. Released June 11, 2025. Accessed June 11, 2025. BeiGene USA, Inc.; Accessed June 11, 2025.
link] Recent Videos Related Content Looking Beyond mRNA-based COVID-19 Vaccines to Innovative Therapeutics Cheryl Barton June 24th 2025 Article mRNA technologies offer great promise in immunotherapy and non-immunogenic applications. Text sign showing Industry News. The Impact of USP Chapter on Endotoxin Testing. PharmTech.com.
Published June 18, 2025 Amy Baxter Staff Reporter post share post print email license stock via Getty Images Listen to the article 6 min This audio is auto-generated. A bill introduced in Congress fulfills a Trump administration goal of ending direct pharma ads to patients. Is DTC pharma advertising coming to an end?
According to a Reuters article, pharma companies launched new US drugs at prices 35% higher in 2023, compared to those launched in 2022. How will RFK Jr’s American dream for vaccines play out? There has been a push by the Trump administration to increase biosimilar and generic drug use in the US.
4 However, a recent article highlighted that AI-discovered molecules have an 80-90% success rate, substantially higher than historic industry averages. AI-based optic systems, for example, can enhance defect screening in manufacturing by scanning for packaging defects.
Recent Videos Related Content Why You Should Know About a New Weekly Injectable for Parkinson’s Christopher Cole July 15th 2025 Article Biodegradable weekly implant delivers stable levodopa levels, aiming to streamline Parkinson’s care while reshaping drug reformulation and delivery strategies. Press Release. June 24, 2025.
This article is produced as part of GlobalData’s Price Intelligence (POLI) service , the world’s leading resource for global pharmaceutical pricing, HTA and market access intelligence integrated with the broader epidemiology, disease, clinical trials and manufacturing expertise of GlobalData’s Pharmaceutical Intelligence Center.
This article uncovers the hidden elements of market access success, revealing what it takes to move from FDA approval to formulary inclusion, provider buy-in, and patient adoption.
Andrew Harnik via Getty Images Listen to the article 6 min This audio is auto-generated. Published June 30, 2025 Amy Baxter Staff Reporter post share post print email license FDA Commissioner Dr. Marty Makary speaks during a news conference at HHS on April 22, 2025 in Washington, DC. Please let us know if you have feedback.
Supporting sterile barrier packaging and supply chain resilience The Madison plant reinforces the TekniPlex Healthcare’s goal of assisting pharma and medical companies, which indirectly includes its downstream partners as well. Suj Mehta Named CEO of TekniPlex Healthcare. February 18, 2025. Accessed June 18, 2025.
Editor’s note: This article was updated shortly after publication to include comment from Eisai and Eli Lilly. Kisunla is forecast to hit $1.6bn in sales by 2031, while Leqembi will achieve sales of $3.8bn by the same year. GlobalData is the parent company of Pharmaceutical Technology. Sign up for our daily news round-up!
This article is produced as part of GlobalData’s Price Intelligence (POLI) service , the world’s leading resource for global pharmaceutical pricing, HTA and market access intelligence integrated with the broader epidemiology, disease, clinical trials and manufacturing expertise of GlobalData’s Pharmaceutical Intelligence Center.
Published June 11, 2025 Amy Baxter Staff Reporter post share post print email license Win McNamee via Getty Images Listen to the article 5 min This audio is auto-generated. Plus, the package would require all rebates or discounts received by PBMs to be passed on to a Medicare Part D plan sponsor, according to a recent brief by Mintz.
Recent Videos Related Content EMA Moves to Secure Supply of Critical Drugs Used During Pregnancy Susan Haigney July 10th 2025 Article The agency’s Executive Steering Group on Shortages and Safety of Medicinal Products has issued recommendations to address vulnerabilities in the supply chain of anti-D immunoglobulins. Press Release.
New individual users receives a 14-day free trial to the UpToDate Lexidrug Hospital Pharmacist Package. Explain Medicine A reliable and accessible medical article repository, offering a quick refresher for healthcare professionals. Miscellaneous Clinical Sense Sharpen your clinical skills by exploring realistic interactive scenarios.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content